IRVINE, Calif., Feb. 9 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation ,announced today that Paul J. McCormick, Executive Chairman, is scheduled to present at the 5th Annual Stem Cell Summit in New York on Tuesday, February 16, 2010 at 3:21 pm Eastern time.
About Cardiogenesis Corporation
Cardiogenesis is a medical device company specializing in the therapies for the treatment of chronic cardiac ischemia. The company’s market leading Holmium:YAG laser system and disposable fiber-optic accessories are used to perform a FDA-cleared surgical procedure known as Transmyocardial Revascularization (TMR) to treat patients suffering from angina. Surgical products and accessories for the Cardiogenesis TMR procedure, which are marketed in the U.S. and around the world, have been shown to reduce angina and improve the quality of life in patients with coronary artery disease. For more information on the company and its products, please visit the Cardiogenesis website at http://www.cardiogenesis.com.
CONTACT: Paul McCormick, Executive Chairman of Cardiogenesis Corporation,
+1-949-420-1808
Web site: http://www.cardiogenesis.com/
http://www.stemcellsummit.com/
